Farletuzumab

http://dbpedia.org/resource/Farletuzumab an entity of type: Thing

فارليتوزوماب هو جسم مضاد وحيد النسيلة في طور المرحلة الثالثة من التجارب السريرية لاستخدامه في علاج سرطان المبيض. طورته شركة مورفوتك (Morphotek, Inc). rdf:langString

Farletuzumab (MORAb-003) is a humanized monoclonal antibody of IgG1/κ which is being investigated for the treatment of ovarian cancer. This drug was developed by Morphotek, Inc. It is targeted at folate receptor alpha (FRα) which is overexpressed in some cancers such as epithelial ovarian cancer (EOC) and non-small-cell lung carcinoma. rdf:langString

Il farletuzumab o MORAb-003, è un anticorpo monoclonale umanizzato. studiato per il trattamento del tumore dell'ovaio. Il farmaco è sviluppato dalla , Inc. Il target molecolare del farmaco è l'antigene: FR-alpha. rdf:langString

rdfs:label

rdf:langString فارليتوزوماب

rdf:langString Farletuzumab

dbpedia-owl:wikiPageID

xsd:integer 19841629

dbpedia-owl:wikiPageRevisionID

xsd:integer 1121297447

dbpprop:atcPrefix

rdf:langString none

dbpprop:c

xsd:integer 6466

dbpprop:casNumber

xsd:integer 896723

dbpprop:chemspiderid

rdf:langString none

dbpprop:h

xsd:integer 9928

dbpprop:kegg

rdf:langString D09343

dbpprop:n

xsd:integer 1716

dbpprop:o

xsd:integer 2020

dbpprop:routesOfAdministration

rdf:langString Intravenous injection

dbpprop:s

xsd:integer 42

dbpprop:source

rdf:langString zu

dbpprop:type

rdf:langString mab

dbpprop:unii

xsd:integer 2

dbpprop:verifiedfields

rdf:langString changed

dbpprop:verifiedrevid

xsd:integer 457123161

dbpprop:watchedfields

rdf:langString changed

dbpedia-owl:abstract

rdf:langString فارليتوزوماب هو جسم مضاد وحيد النسيلة في طور المرحلة الثالثة من التجارب السريرية لاستخدامه في علاج سرطان المبيض. طورته شركة مورفوتك (Morphotek, Inc).

rdf:langString Farletuzumab (MORAb-003) is a humanized monoclonal antibody of IgG1/κ which is being investigated for the treatment of ovarian cancer. This drug was developed by Morphotek, Inc. It is targeted at folate receptor alpha (FRα) which is overexpressed in some cancers such as epithelial ovarian cancer (EOC) and non-small-cell lung carcinoma.

rdf:langString Il farletuzumab o MORAb-003, è un anticorpo monoclonale umanizzato. studiato per il trattamento del tumore dell'ovaio. Il farmaco è sviluppato dalla , Inc. Il target molecolare del farmaco è l'antigene: FR-alpha.

dbpprop:mabType

rdf:langString mab

dbpedia-owl:wikiPageLength

xsd:nonNegativeInteger 3633

dbpedia-owl:casNumber

xsd:string 896723-44-7

dbpedia-owl:fdaUniiCode

xsd:string 2O09BG0OWA

dbpedia-owl:kegg

xsd:string D09343

rdf:type

owl:Thing